CClinicalTrials.gg
Status unknownNCT02924948Updated Oct 5, 2016

A Comparison of Endoscopic Ultrasound Insertion Methods

An interventional study of Balloon inflation in Throat Pain After EUS Insertion, sponsored by Seoul National University Hospital. Status unknown. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-05.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
482
Allocation
Randomized
Ages
20 Years to 80 Years
Sex
All
01

Study summary

Endoscopic ultrasonography (EUS) is an essential technique required in diagnosis of pancreatobiliary diseases. In previous studies, 6% of patients who undergone EUS had significant throat pain. (NRS scale 5 or greater) Although some endoscopists think balloon inflation while EUS insertion could result in decreased throat damage and pain, there is no data to back up. We designed a single center randomized pilot study to compare throat pain caused by EUS insertion with conventional vs balloon inflation method.

Read the detailed description

All patients who are undergoing EUS with radial type echoendoscope will be asked for an informed consent. Subjects will be randomized to conventional insertion arm and balloon inflated insertion arm. All patients will be sedated according to SNUH endoscopy center protocol. Conventional insertion will be done in conventional insertion group, and balloon inflation before the start of procedure will be done in balloon inflated insertion arm. After the EUS procedure is finished, subject will be moved to a recovery room. As soon as the subject is recovered from sedation, throat pain will be assessed in NRS scale and be recoreded. Information of insertion failure and balloon damage during insertion will be also collected.

02

Conditions studied

  • Throat Pain After EUS Insertion

Keywords

  • Endoscopic ultrasonography
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients aged from 20 to 80
  • Patients undergoing EUS with radial echoendoscope

Exclusion criteria

Exclusion Criteria:

  • Refuse to participate the study
  • Refuse EUS procedure
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
482 participants (estimated)

Study arms

  • No intervention
    Conventional insertion

    EUS will be inserted with conventional method.

  • Experimental
    Balloon inflated insertion

    EUS will be inserted with balloon inflated method

    Procedure: Balloon inflation

Interventions

  • ProcedureBalloon inflation

    EUS balloon inflation will be done before insertion through the subjects throat

06

What researchers measure

Primary outcomes

  1. Throat pain

    Throat pain assessed by NRS scale 5 or over will be considered as positive

    Time frame: Assess right after the end of the EUS procedure

Secondary outcomes

  1. Throat pain intensity

    Throat pain assessed in NRS scale which has a range of 0 to 10

    Time frame: Assess right after the end of the EUS procedure

  2. EUS Insertion failure rate

    To assess the EUS insertion failure rate

    Time frame: Right after insertion

  3. Damaged balloon rate

    Inability to inflate the balloon after insertion of EUS will be counted

    Time frame: during EUS procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02924948
Lead sponsor
Seoul National University Hospital
Responsible party
Sponsor
First posted
Oct 5, 2016
Start date
Sep 2016
Primary completion
Sep 2019 (estimated)
Completion
Sep 2019 (estimated)
Last update
Oct 5, 2016

Study contacts

Sang Hyub Lee, MD. PhD.
Contact
gidoctor@snuh.org
82-2-2072-2228
Sang Hyub Lee, MD. PhD
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion